flavin-adenine-dinucleotide has been researched along with Kidney-Neoplasms* in 2 studies
2 other study(ies) available for flavin-adenine-dinucleotide and Kidney-Neoplasms
| Article | Year |
|---|---|
Raloxifene, identified as a novel LSD1 inhibitor, suppresses the migration of renal cell carcinoma.
Topics: Antineoplastic Agents; Binding Sites; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Movement; Cell Survival; Drug Evaluation, Preclinical; Enzyme Inhibitors; Flavin-Adenine Dinucleotide; Histone Demethylases; Humans; Kidney Neoplasms; Molecular Docking Simulation; Raloxifene Hydrochloride | 2021 |
A study for the detection of kidney cancer using fluorescence emission spectra and synchronous fluorescence excitation spectra of blood and urine.
In this study, we compared different types of biomolecular markers in kidney cancer patients and in normal healthy controls, using fluorescence emission spectra and synchronous fluorescence excitation spectra. We were able to provide an accurate classification of the spectral features of kidney cancer patients relative to that of normal controls, in terms of the concentration ratios of biomolecules (viz., tryptophan, NADH, FAD, basic porphyrin, and acidic porphyrin) based on the intensity of their spectral peaks. The specificity and sensitivity of the method were 90%. The rationale of our current approach is to evolve an innovative protocol for the spectral characterization of in vitro optical analyses suitable for both small clinics and hospitals. Topics: Adult; Biomarkers, Tumor; Female; Flavin-Adenine Dinucleotide; Humans; Kidney Neoplasms; Male; Middle Aged; NAD; Porphyrins; Sensitivity and Specificity; Spectrometry, Fluorescence; Tryptophan | 2018 |